- POČETNA
- O NAMA
- AKTUALNO
- MEĐUNARODNE ASOCIJACIJE
- KONTAKT
- POVEZNICE
- PRAVA PACIJENATA
- ORGANIZACIJE
- Hrvatsko društvo za hematologiju hrvatskog liječničkog zbora (HRDH)
- Hrvatska kooperativna udruga za hematološke bolesti – KROHEM
- The European Hematology Association (EHA)
- The European Group for Blood and Marrow Transplantation (EBMT)
- The European Organisation for Research and Treatment of Cancer (EORTC)
- European LeukemiaNet
- The American Society of Hematology (ASH)
- The American Society for Blood and Marrow Transplantation (ASBMT)
- The International Society of Hematology (ISH)
- The American Society of Pediatric Hematology/Oncology (ASPHO)
- The Society for Hematology and Stem Cells (ISEH)
- The International Myeloma Foundation (IMF)
- The Society for Immunotherapy of Cancer (SITC)
- The International Society on Thrombosis and Haemostasis (ISTH)
- The Society for Hematopathology
- The American Society of Clinical Oncology (ASCO)
- The European Society for Medical Oncology (ESMO)
- ČASOPISI
Lymphoma Coalition 2020 Global Patient Survey - Week 3 Update
Dear Members,
To date, we have received 3305 responses (patient and caregiver surveys combined) to the 2020 Global Patient Survey on Lymphomas & CLL. This week we have seen an increase in the number of groups who will receive a country report, and there are a number of others who are close.
Promoting the survey works and we encourage each group to participate. Keep reading to the end of this email for more information on marketing the survey, including information on what has been translated for your use.
See below for the survey count by member countries for patient respondents. Please remember caregivers have their own survey this year and these numbers are being tracked separately.
COUNTRY | SURVEYS | COUNTRY | SURVEYS |
Algeria | 1 | Latvia | 0 |
Argentina | 56 | Lithuania | 26 |
Australia | 111 | Macedonia | 0 |
Barbados | 1 | Mexico | 3 |
Belgium | 89 | Morocco | 9 |
Brazil | 4 | New Zealand | 184 |
Bulgaria | 42 | Norway | 3 |
Canada | 259 | Poland | 0 |
China | 2 | Portugal | 8 |
Colombia | 1 | Romania | 1 |
Croatia | 10 | Russia | 0 |
Czech Republic | 1 | Serbia | 59 |
Denmark | 8 | Singapore | 0 |
Finland | 39 | Slovakia | 26 |
France | 866 | Slovenia | 10 |
Germany | 31 | South Africa | 4 |
Greece | 3 | Spain | 4 |
Hong Kong | 2 | Sweden | 147 |
Hungary | 2 | Switzerland | 35 |
India | 51 | The Netherlands | 51 |
Iraq | 0 | Turkey | 1 |
Ireland | 20 | Ukraine | 0 |
Israel | 0 | United Kingdom | 179 |
Italy | 153 | United States | 312 |
Japan | 5 | Uruguay | 9 |
Korea | 4 | Venezuela | 1 |
The highlighted countries have surpassed 100 respondents, and will receive a country report.
Congratulations to Blodcancerförbundet in Sweden who have qualified for a country report for the first time with 147 patient respondents! Cheers to Australia, Italy and New Zealand, who have seen a substantial jump in survey responses this week. As well, both France Lymphome Espoir and SILLC have worked hard promoting the survey, resulting in the highest number of respondents we have ever had from France.
We have also tracked the survey completion counts by subtype from patient respondents:
SUBTYPE | SURVEYS |
Anaplastic large cell | 17 |
Burkitts | 34 |
CL | 144 |
CLL/SLL | 755 |
DLBCL (unspecified) | 290 |
DLBCL (GCB) | 22 |
DLBCL (ABC) | 34 |
Extranodal Killer T-cell | 0 |
FL | 383 |
HL | 412 |
MALT | 40 |
Mantle cell | 69 |
Peripheral T-cell | 26 |
Transformed | 37 |
WM | 400 |
The highlighted subtypes have surpassed 100 respondents, and will have a subtype report.
Thank you to everyone who has already shared the 2020 Global Patient Survey. For those that have not done so, please share the link with your membership, healthcare community and social media. The marketing materials can be found on the members side of the LC website. The materials have all been translated into the same 19 languages that the survey is offered in. CLICK HERE to access them. Your login is required. If you need help with your username and password, please contact marketing@lymphomacoalition.
Here's what you can do to help us reach our goal:
All your efforts to help promote participation in the 2020 Global Patient Survey are greatly appreciated.
Reminder – countries with 100+ respondents (from patients) will receive a specialised by country report.
Together, we will ensure patients are given the opportunity to share their experience and help shape the global lymphoma landscape.
Warm regards,
Lorna
Podijeli
Hrvatska udruga leukemija i limfomi
predsjednik Dražen Vincek
Trg hrvatskih velikana 2/ll
10 000 Zagreb
GSM: +385 (0)91 4873 561
TEL: +385 (0)1 4873 561
e-mail: udruga.hull.zagreb@gmail.com
Web adresa: www.hull.hr
IBAN: HR 36 2340 0091 1100 4711 4
SWIFT CODE: PBZGHR2X